Clover Biopharmaceuticals Reports Positive Phase III Data for COVID-19 Vaccine SCB-2019
China-based Clover Biopharmaceuticals Ltd (HKG: 2197) has announced additional positive Phase III clinical trial data...
Vaccine
Zhong’ao Biopharmaceutical Secures Series A Funding for Cancer and HPV-Related Disease R&D
China-based Zhong’ao Biopharmaceutical Technology (Guangdong) Co., Ltd. has reportedly raised an undisclosed amount of money...
Luye Life Sciences Partners with Uzbekistan to Establish Vaccine Center
China-based Luye Life Sciences Group has struck a partnership with the Ministry of Innovation and...
Guangdong Launches Free HPV Vaccination Program for School-aged Girls
Guangdong province has rolled out a free HPV vaccination program this month, aimed at improving...
China’s Cecolin HPV Vaccine Shows 100% Efficacy in 66-Month Study
Chinese researchers have published 66-month follow-up data from a Phase III clinical study for the...
Walvax Biotech Enrolls First Subject in Phase III HPV Vaccine Study
China’s Walvax Biotechnology Co., Ltd (SHE: 300142) announced the first subject enrollment for a Phase...
Clover Biopharmaceuticals’ COVID-19 Vaccine SCB-2019 Shows Superior Booster Efficacy in Phase III Trial
China-based Clover Biopharmaceuticals Ltd (HKG: 2197) reported positive Phase III trial results for its COVID-19...
CanSino, Livzon Win China EUAs for COVID-19 Booster Vaccines
China-based vaccine makers CanSino Biologics (HKG: 6185) and Livzon Pharmaceutical Group Inc. (HKG: 1513) have...
Walvax Biotech Wins NMPA Approval for mRNA and Recombinant COVID-19 Vaccines
China’s Walvax Biotechnology Co., Ltd (SHE: 300142) has received clinical trial approvals from the National...
Biointron Raises USD 72M in Series B to Expand CRO Services and Antibody Platform
Shanghai-based Biointron, a recombinant protein/antibody reagent contract research organization (CRO), has raised nearly RMB 500...
Kangtai Bio Partners with Philippine Firm on Pneumonia Vaccines
Shenzhen Kangtai Biological Products Co., Ltd (SHE: 300601) has partnered with an unnamed Philippine enterprise...
Merck’s Gardasil 9-Valent HPV Vaccine Approved for Expanded Age Range in China
US-based Merck Sharp & Dohme (MSD; NYSE: MRK) announced that China’s National Medical Products Administration...
Clover Biopharma’s SCB-2019 Vaccine Shows Strong Immune Response to Omicron BA.5
China-based Clover Biopharmaceuticals, Ltd (HKG: 2197) announced positive Phase II/III trial results for its COVID-19...
Fosun Pharma to Invest RMB 1B in Chengdu Vaccine Base
Shanghai Fosun Pharmaceutical (Group) Co., Ltd (SHA: 600196) announced that its subsidiaries, Shanghai Fosun Pharmaceutical...
Clover Biopharmaceuticals’ SCB-2019 Vaccine Proves Effective in Teenagers
China-based Clover Biopharmaceuticals Ltd (HKG: 2197) announced positive results from a global Phase II/III trial...
CSPC Pharmaceutical’s SYS6006 mRNA Vaccine Shows Strong Safety and Efficacy in Trials
China-based CSPC Pharmaceutical Group Ltd (HKG: 1093) has provided updates on its in-house COVID-19 mRNA...
China Passes WHO NRA Evaluation for Vaccine Regulatory System
The World Health Organization (WHO) announced that China has successfully passed the evaluation of its...
Recbio Completes Enrollment for HPV Vaccine REC603 Immuno-Bridging Study
China-based vaccine maker Jiangsu Recbio Technology Co., Ltd (HKG: 2179) announced the completion of subject...
AstraZeneca’s H1 2022 Revenues Surge 48%, Led by Oncology and Vaccines
UK-based AstraZeneca (AZ, NASDAQ: AZN) released its financial report for H1 2022, showing a 48%...
CanSino Biologics Launches Menhycia Meningococcal Vaccine in Six Provinces
China-based CanSino Biologics (HKG: 6185) announced the launch of its ACYW135 Meningococcal Conjugate Vaccine (CRM197)...